The pilot worked because the team worked around it.
Manual routing, cleanup, and exception handling may still be doing the hard part.
GNS-AI identifies where AI can create operating value, defines the product, and leads the design and build of AI products and agentic systems. For consequential workflows, we also test production readiness and govern what AI is allowed to make happen through the Decision Control Plane.

AI governance becomes real when the workflow must decide what may proceed, what requires review, and who owns the consequence.
Manual routing, cleanup, and exception handling may still be doing the hard part.
A missing prerequisite can matter more than a high-confidence answer.
The organization still has to explain why the action was permitted.
GNS-AI can help decide what deserves to be built, turn the selected opportunity into a working AI product or agentic system, or determine whether the system is ready to scale.
Use when leadership has many AI ideas but no defensible order of investment. GNS-AI identifies the strongest use cases, defines the product or internal capability, and recommends what to build, buy, partner on, test, or stop.
Review AI product strategyUse when the opportunity is selected and the organization needs the product, workflow, agent behavior, human roles, data, interfaces, and working pilot or production system designed and built.
Review product developmentUse when leadership must decide whether a product, pilot, vendor, agent, or workflow is ready to buy, launch, expand, redesign, or stop.
Review Production AssuranceNot ready to commission a full engagement? The fixed-fee AI Initiative Review is a five-day written assessment for leaders deciding whether to fund, extend, narrow, or stop an initiative. $3,500, credited in full against a larger engagement scoped within 90 days.
Dr. Shah brings a biomedical engineering doctorate, enterprise data and AI leadership at Abbott Diagnostics, healthcare AI work at Apricity Health, and federal health education through HRSA-sponsored programs.
Scientific training in human adaptation and decision boundaries, followed by applied work in diagnostics, healthcare AI, enterprise data, simulation, and production systems.
Founder-led architecture, decision design, production assurance, and Decision Control Plane shadow-mode work for consequential workflows.
GNS-AI is still building customer-validated evidence for the current platform and packaged engagements. Prior operating results are identified as Dr. Shah’s experience, not presented as GNS-AI client outcomes.
Review Dr. Shah’s background and the company’s evidence boundaries
Healthcare and payer, federal and public-sector, and enterprise and industrial workflows.

Care, access, utilization, referral, and rehabilitation.
Explore healthcare
Connect mission authority, evidence, acquisition, and operational review.
Explore federal
Preserve system knowledge and expose dependencies before critical change.
Explore enterprise & industrialIt applies approved authority to each case and records whether AI influence should proceed, pause, escalate, or stop, without changing production authority during the pilot.
Assess before scaling.
The answers determine whether the need is product strategy, development, production assurance, governance, or decision control.
GNS-AI is best suited to AI products and workflows tied to a real operating result. The work can begin with use-case selection, product strategy, design and development, a pilot or vendor decision, production assurance, or a live consequential workflow that needs operational governance.
Yes. GNS-AI can identify and rank use cases, define the product and business case, design the workflow and operating model, and lead development of a bounded AI product or agentic system. Agentic architecture is used when the work genuinely requires tool use, evidence gathering, coordination, or escalation.
The first purchase can be a fixed-fee AI Initiative Review, an AI Decision System Working Session, an AI Product and System Blueprint, a scoped product or agentic-system pilot, or Production Assurance. When AI already influences a consequential live workflow, the entry path can be a DCP Shadow Pilot.
No. Each engagement ends with a decision about what should proceed, change, be tested, or stop. Product development, production implementation, and DCP licensing are separately scoped only when the evidence and business case justify the next commitment.
Bring the use case portfolio, product idea, workflow, pilot, or live decision that must improve. GNS-AI will route it to the smallest appropriate strategy, development, assurance, governance, or DCP engagement.
Research and practical analysis on AI products, agentic systems, production assurance, governance, and decision control. Published by Dr. Amit K. Shah.